GusellaJF, WexlerNS, ConneallyPM, et al.A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 1983; 306:234–238.
2.
TanziRE, GusellaJF, WatkinsPC, et al.Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 1987; 235:880–884.
3.
KovacsDM, FausettHJ, PageKJ, et al.Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med, 1996; 2:224–249.
4.
MuramatsuY, YamadaT, MiuraM, et al.Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats. Gastroenterology, 1994; 107:1189–1192.
5.
ChopraD, TanziRE. Super Brain: Unleashing the Explosive Power of Your Mind to Maximize Health, Happiness, and Spiritual Well-being. New York, NY: Harmony, 2013.
6.
ChopraD, TanziRE. Super Genes: Harnessing the Vast Potential of Your Genome for Optimum Health and Well-Being. New York, NY: Random House, 2016.
7.
MuehsamD, LutgendorfS, MillsPJ, et al.The embodied mind: A review on functional genomic and neurological correlates of mind–body therapies. Neurosci Biobehav Rev, 2017; 73:165–181.
8.
PetersonCT, LucasJ, John-WilliamsLS, et al.Identification of altered metabolomic profiles following a Panchakarma-based Ayurvedic intervention in healthy subjects: The Self-Directed Biological Transformation Initiative (SBTI). Sci Rep, 2016; 6:3260–9.
9.
VahidF, ZandH, Nosrat-MirshekarlouE, et al.The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review. Gene, 2015; 562:8–15.
10.
BettioLEB, RajendranL, Gil-MohapelJ. The effects of aging in the hippocampus and cognitive decline. Neurosci Biobehav Rev, 2017; 79:66–86.
11.
LuceyBP, BatemanRJ. Amyloid-β diurnal pattern: Possible role of sleep in Alzheimer's disease pathogenesis. Neurobiol Aging, 2014; 35Suppl 2:S29–34.
12.
UllandTK, SongWM, HuangSC, et al.TREM2 maintains microglial metabolic fitness in Alzheimer's disease. Cell, 2017; 170:649–663.
13.
SarmaA, BemisM, DesiletsAR. Role of medium chain triglycerides (Axona®) in the treatment of mild to moderate Alzheimer's disease. Am J Alzheimers Dis Other Demen, 2014; 29:409–414.
14.
ChoiSH, KimYH, HebischM, et al.A three-dimensional human neural cell culture model of Alzheimer's disease. Nature, 2014; 515:274–278.
15.
ChoiSH, KimYH, QuintiL, et al.3D culture models of Alzheimer's disease: A road map to a “cure-in-a-dish.”. Mol Neurodegener, 2016; 11:75.
16.
GlennerGG. Amyloid beta protein and the basis for Alzheimer's disease. Prog Clin Biol Res, 1989; 317:857–868.
17.
SehgalN, GuptaA, ValliRK, et al.Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A, 2012; 109:3510–3515.
18.
WesPD, SayedFA, BardF, GanL. Targeting microglia for the treatment of Alzheimer's disease. Glia, 2016; 64:1710–1732.
19.
SevignyJ, ChiaoP, BussièreT, et al.The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature, 2016; 537:50–56.
20.
SchluesenerHJ, SuY, EbrahimiA, PouladsazD. Antimicrobial peptides in the brain: Neuropeptides and amyloid. Front Biosci (Schol Ed), 2012; 4:1375–1380.
21.
KumarDK, ChoiSH, WashicoskyKJ, et al.Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med, 2016; 8:340ra7–2.
22.
GoldsteinLE, FisherAM, TaggeCA, et al.Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med, 2012; 4:134ra6–0.
